Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01886001 · ClinicalTrials.gov registry record · NA

Topical Umbilical Cord Care for the Prevention of Colonization and Invasive Infections

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
53
Enrollment target

NCT01886001: Completed NA study, sponsored by University of Virginia.

NCT01886001 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01886001, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

Umbilical catheters are necessary for many infants admitted to the Newborn Intensive Care Unit (NICU)and utilized when indicated for up to 7 to 14 days. Bacterial colonization can occur at the umbilical stump and potentially lead to serious bloodstream infections (BSIs). This study is a prospective, randomized controlled feasibility trial to evaluate three types of hygiene products on umbilical line stumps, on the effect of line colonization and subsequent infections. Infants admitted to the NICU with an umbilical line(s) will be randomized into one of four study groups, three products against standard of care (no product). The three products that will be evaluated are currently being used in different capacities for skin care in the UVA NICU. The study hypothesizes that daily topical application of 1 or more antiseptic to the top of the umbilical stump will decrease colonization of the umbilical stump while umbilical lines are in place.

Interventions

  • OTHER Control
  • DRUG Povidone-Iodine
  • DRUG Chlorhexidine
  • DRUG Pluronic

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2012-11
Est. Completion 2013-07
Phase NA
University of Virginia

449 total trials

What the finished NCT01886001 record still lists

NCT01886001 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 4 interventions - of which Control is the first listed.

NCT01886001 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01886001 about?

NCT01886001 is a clinical study titled "Topical Umbilical Cord Care for the Prevention of Colonization and Invasive Infections". Umbilical catheters are necessary for many infants admitted to the Newborn Intensive Care Unit (NICU)and utilized when indicated for up to 7 to 14 days. Bacterial colonization can occur at the umbilical stump and potentially lead to serious bloodstream infections (BSIs). This study is a prospective,...

What is the current status of trial NCT01886001?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2012-11. Estimated completion is 2013-07.

What interventions are being tested in trial NCT01886001?

The interventions under investigation include: Control (OTHER), Povidone-Iodine (DRUG), Chlorhexidine (DRUG), Pluronic (DRUG).

Who is sponsoring clinical trial NCT01886001?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01886001's enrollment target sits among peer trials

53 1271st of 2000 higher than 729 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01886001, the US trial registry maintained by the National Library of Medicine. NCT01886001 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.